INTERPACE BIOSCIENCES, INC. (IDXG) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2010: $16.35M2011: $1.99M2012: -$10.29M2013: -$3.51M2014: -$16.38M2015: -$19.84M2016: -$7.61M2017: -$15.26M2018: -$8.67M2019: -$18.96M2020: -$13.98M2021: -$8.72M2022: -$7.69M2023: $3.79M2024: $4.65M2025: $5.83M$5.83M
2010Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025$5.83M+25.5%
2024$4.65M+22.6%
2023$3.79M+149.3%
2022-$7.69M+11.8%
2021-$8.72M+37.6%
2020-$13.98M+26.3%
2019-$18.96M-118.6%
2018-$8.67M+43.2%
2017-$15.26M-100.6%
2016-$7.61M+61.7%
2015-$19.84M-21.2%
2014-$16.38M-366.3%
2013-$3.51M+65.9%
2012-$10.29M-618.2%
2011$1.99M-87.9%
2010$16.35M